about
Ca2+-dependent modulation of voltage-gated Ca2+ channelsCa2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sitesHistone deacetylase signaling in cardioprotectionRecent advances in understanding cardiac contractility in health and diseaseCardiac cAMP: production, hydrolysis, modulation and detectionRegulation of CaMKII signaling in cardiovascular diseaseOngoing controversies surrounding cardiac remodeling: is it black and white-or rather fifty shades of gray?The role of late I Na in development of cardiac arrhythmiasSignaling effectors underlying pathologic growth and remodeling of the heartIon Channels in the Heart'Ryanopathy': causes and manifestations of RyR2 dysfunction in heart failureRegulation of thrombosis and vascular function by protein methionine oxidationCaMKII-dependent regulation of cardiac Na(+) homeostasisThe role of O-GlcNAc transferase in regulating the gene transcription of developing and failing heartsNa+ channel function, regulation, structure, trafficking and sequestrationMechanisms of altered Ca²⁺ handling in heart failureCa(2+) current facilitation is CaMKII-dependent and has arrhythmogenic consequencesCompartmentalization of β-adrenergic signals in cardiomyocytesRole of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death.Structural Dynamics and Topology of Phosphorylated Phospholamban Homopentamer Reveal Its Role in the Regulation of Calcium TransportOxidative activation of Ca(2+)/calmodulin-activated kinase II mediates ER stress-induced cardiac dysfunction and apoptosismiR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathwaysCaMKII determines mitochondrial stress responses in heartAerobic interval training partly reverse contractile dysfunction and impaired Ca2+ handling in atrial myocytes from rats with post infarction heart failureCaMKII inhibition reduces isoproterenol-induced ischemia and arrhythmias in hypertrophic mice.Cardiac Na Channels: Structure to FunctionProtein Kinase Signaling at the Crossroads of Myocyte Life and Death in Ischemic Heart Disease.CaMKII regulation of cardiac ryanodine receptors and inositol triphosphate receptors.Experimentally increasing titin compliance in a novel mouse model attenuates the Frank-Starling mechanism but has a beneficial effect on diastole.Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytesEffects of Wenxin Keli on Cardiac Hypertrophy and Arrhythmia via Regulation of the Calcium/Calmodulin Dependent Kinase II Signaling Pathway.CaMKII comes of age in cardiac health and disease.Nitric oxide induces Ca2+-independent activity of the Ca2+/calmodulin-dependent protein kinase II (CaMKII).Gene expression and β-adrenergic signaling are altered in hypoplastic left heart syndrome.Three ways to die suddenly: do they all require calcium calmodulin-dependent protein kinase II?Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptorThe potential role of Kv4.3 K+ channel in heart hypertrophy.Glutathionylation of the L-type Ca2+ channel in oxidative stress-induced pathology of the heart.Alteration in mitochondrial Ca(2+) uptake disrupts insulin signaling in hypertrophic cardiomyocytes.Intracellular Na+ overload causes oxidation of CaMKII and leads to Ca2+ mishandling in isolated ventricular myocytes.
P2860
Q21564049-C1A57500-E56E-4DC0-AF92-1D3034C0274AQ24315218-CD67C7BE-EC50-4489-BA38-F7761DDBEF1EQ24568237-291E10EB-A77A-4B78-9A36-BA69A0D30E83Q26742055-B4DEF4E9-521E-4AE3-B9A1-0EEEAD2E070BQ26781612-960061EC-1984-4EF9-9B6D-816A03A8849CQ26785302-D946D7F3-79D5-4748-BD2C-A3C7F9FCA9BDQ26800197-4372362C-6295-44C6-9028-BF1BA8117439Q26823149-073CD8FC-0638-4CEC-B5EB-829ADC62BF57Q26825154-925BA77D-AB63-4F59-B012-30214A7CA4B0Q26829681-17DB6582-BFBD-4A33-9D75-04F63B369AEBQ26865421-9DE3315E-C328-4690-BC5B-7607246D1277Q26865448-F19011E6-6698-4B44-8D3B-D076BE4F8349Q26997372-64BEE406-0A46-4988-95A0-A3801C777B53Q27005703-B48813D3-C6D1-452F-B90E-514C38437835Q27005721-23AC6318-9689-4924-85DB-D76F0089CFB8Q27012758-9F2D9D28-BD7F-4C62-8B2D-6E5278156B22Q27013621-CA2B7ECC-028C-4EAD-AB59-184F66B53C75Q27026992-BD3135B2-A05F-432F-BC6E-05314068BF98Q27339434-AFDEA86D-0500-4715-9585-B23C04CD2DC6Q27680562-334EAA79-845B-4C95-BC46-039FA76C0FD2Q28283224-E538AEC8-6572-449A-934C-BFA17199276BQ28544014-518E561B-A5A5-4AFF-9381-020AB4D317C2Q28591986-4F67A074-27A3-45A4-9E9C-3885673771E1Q31120867-6A983D3A-A37A-4715-B077-4B1F0A3125F0Q33566547-E37B15FF-566A-40CB-81D8-8DFCEEE052E6Q33583786-4CD53797-BC6D-4AFB-899B-0AEC5DCA0E63Q33604010-3978E573-6829-42C8-9CD9-318F4C3777D8Q33611715-9798CF91-0C5E-43D9-BCC7-595D2287E674Q33654696-D6D9E999-DD9D-4CCA-BD9C-142A6F6CDDFDQ33707376-5B5C8CF8-F3F1-4684-A346-F91D728B72A5Q33716249-02CC2768-0062-4D7D-9AC5-096B5CA0DE14Q33839892-6CBD20A1-010F-4FF0-B2A1-648F129C74C4Q33888523-EB9E5EBE-A1FC-4725-960B-A6CF11F43281Q33954281-9F250B18-BA83-4B9A-A21F-76829DDCA66AQ33957736-6A915F0C-0089-4090-8D7C-DC12B0AE268DQ34004829-47C18452-FCF4-491F-B74D-C57FB33AFD95Q34373955-002B689F-D584-4C5D-B947-7B4C272FBE71Q34487060-0FE955E3-49BB-4ECE-ACC1-873B4DDFBDC0Q34528162-484F0E77-8230-4C4F-925F-5AD95D3F6DB3Q34603278-AC844E25-FA8D-4BC2-9C66-1DF1B7CA8290
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CaMKII in myocardial hypertrophy and heart failure
@en
CaMKII in myocardial hypertrophy and heart failure.
@nl
type
label
CaMKII in myocardial hypertrophy and heart failure
@en
CaMKII in myocardial hypertrophy and heart failure.
@nl
prefLabel
CaMKII in myocardial hypertrophy and heart failure
@en
CaMKII in myocardial hypertrophy and heart failure.
@nl
P2860
P1476
CaMKII in myocardial hypertrophy and heart failure
@en
P2093
Joan Heller Brown
Mark E Anderson
P2860
P304
P356
10.1016/J.YJMCC.2011.01.012
P577
2011-01-27T00:00:00Z